China NT Pharma Mulls Share Issue to Creditors

MT Newswires Live10-10

Trading in the shares of China NT Pharma Group (HKG:1011) resumed on Oct. 10, according to a Thursday filing on the Hong Kong bourse.

The company said it may issue subscription shares to four creditors, including two substantial shareholders, to capitalize outstanding loans and interest.

China NT Pharma sought a trading suspension on Oct. 4 pending the release of the announcement regarding the potential subscription agreements.

The pharmaceutical's shares closed 17% higher on Thursday.

Price (HKD): $0.47, Change: $+0.070, Percent Change: +17.50%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2474248794?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-10 17:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474248794","market":"us","top_or_hot":-1,"title":"China NT Pharma Mulls Share Issue to Creditors","media":"MT Newswires Live","content":"<html><body><p> Trading in the shares of China NT Pharma Group (HKG:1011) resumed on Oct. 10, according to a Thursday filing on the Hong Kong bourse.</p><p>The company said it may issue subscription shares to four creditors, including two substantial shareholders, to capitalize outstanding loans and interest.</p><p>China NT Pharma sought a trading suspension on Oct. 4 pending the release of the announcement regarding the potential subscription agreements.</p><p>The pharmaceutical's shares closed 17% higher on Thursday.</p><p>Price (HKD): $0.47, Change: $+0.070, Percent Change: +17.50%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China NT Pharma Mulls Share Issue to Creditors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina NT Pharma Mulls Share Issue to Creditors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-10 17:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Trading in the shares of China NT Pharma Group (HKG:1011) resumed on Oct. 10, according to a Thursday filing on the Hong Kong bourse.The company said it may issue subscription shares to four creditors...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2474248794","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474248794","pubTimestamp":1728552776,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Trading in the shares of China NT Pharma Group  resumed on Oct. 10, according to a Thursday filing on the Hong Kong bourse.The company said it may issue subscription shares to four creditors, including two substantial shareholders, to capitalize outstanding loans and interest.China NT Pharma sought a trading suspension on Oct. 4 pending the release of the announcement regarding the potential subscription agreements.The pharmaceutical's shares closed 17% higher on Thursday.Price : $0.47, Change: $+0.070, Percent Change: +17.50%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK1191":"制药","BK4526":"热门中概股","BK4023":"应用软件","BK4585":"ETF&股票定投概念","01011":"泰凌医药"},"translate_title":"中国泰凌医药考虑向债权人发行股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01011":0.9},"content_text":"Trading in the shares of China NT Pharma Group (HKG:1011) resumed on Oct. 10, according to a Thursday filing on the Hong Kong bourse.The company said it may issue subscription shares to four creditors, including two substantial shareholders, to capitalize outstanding loans and interest.China NT Pharma sought a trading suspension on Oct. 4 pending the release of the announcement regarding the potential subscription agreements.The pharmaceutical's shares closed 17% higher on Thursday.Price (HKD): $0.47, Change: $+0.070, Percent Change: +17.50%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474248794"}